The MCPA does NOT sell or purchase medical cannabis
Get in the know!
Subscribe to get our latest news and updates!
Menu
“When the legislature formulated the bill, they included a specific section defining the Medical Cannabis Advisory Committee. There are several questions that have arisen from this, and today I will address some of these. These questions not only pertain to the committee but also touch upon the needs and concerns of patients. Let’s begin by examining how the Cannabis law set up this advisory committee.
…A major concern we must address is the timely access to medical cannabis for patients.”
– Angie Calhoun
Jackson, MS, 5/4/2022 – The Mississippi Cannabis Patients Alliance applauds all municipalities and counties across Mississippi who have decided to participate in the Mississippi Medical Cannabis Act. Many cities and counties across the state are supporting patients by allowing the cultivation, processing, testing, distribution, and dispensing of medical cannabis to patients. Those who have opted in are taking a stand in supporting our state’s patients’ medical freedom and their ease of access to quality healthcare. The Mississippi Cannabis Patients Alliance has and will support the most convenient access for eligible patients to medical cannabis.
For municipalities and counties that have decided to opt-out of the Mississippi Medical Cannabis Act, we hope that the Mississippi Cannabis Patients Alliance will be a resource for those local political leaders as they determine future decisions regarding medical cannabis. The Mississippi Cannabis Patients Alliance will continue to support petition drives, fundraising efforts, and continuous outreach to help Mississippi’s patients get access to the medicine they need.
The Mississippi Cannabis Patients Alliance hopes that all municipalities across Mississippi will work to keep open access to medical cannabis for all eligible patients. Over 147,000 Mississippi patients have debilitating conditions that would qualify for access to medical cannabis to alleviate symptoms like chronic pain, improve their ability to withstand life-saving treatments like chemotherapy, and improve their quality of life. This program assists patients across Mississippi in reducing unnecessary utilization of healthcare resources, lowers dependence on opioids and benzos, and gives patients long-sought medical freedom.
The Mississippi Cannabis Patients Alliance is Mississippi’s most trusted voice and resource for patients considering medical cannabis or who have been certified for its use. In addition, the Mississippi Cannabis Patients Alliance is available for patients who want the most current, reliable, and impartial information on how, when, and where to take their next step to improve their quality of life safely and effectively.
For more information, please contact: pr@thehivebrandagency.com.
JACKSON, Miss. (WLBT) – A new partnership could help determine the best ways to use medical marijuana in treating illness.
The Mississippi Cannabis Patients Alliance has announced a new partnership with the University of Mississippi and Releaf App on a new research program that the groups say, “will help the industry, regulators, practitioners, and patients by providing evidence of what products work best for certain… conditions.”
The alliance tags itself as “the unifying voice of over 147,000 patients in Mississippi whose quality of life can improve through the safe and well-regulated use of medical cannabis,” its website states.
JACKSON, Miss. —
Mississippi’s medical cannabis program kicked off about a week ago and now thousands of patients across the state are legally purchasing marijuana to treat qualifying illnesses, including cancer, glaucoma, sickle cell anemia, seizures and chronic pain.
A new partnership aims to find out how effective marijuana is at treating those conditions.
“To be able to walk into a dispensary and know right off the bat what products are going to work for certain debilitating medical conditions,” said Angie Calhoun, with the Mississippi Cannabis Patients Alliance.
A new partnership has been announced to study the effectiveness of cannabis products on the market.
The Mississippi cannabis Patients Alliance, the University of Mississippi and the Releaf App are joining forces to collect data on medical cannabis.
A press conference to announce the partnership is planned for 9:30 a.m. in Jackson.
The research program will help the industry, regulators, practitioners and patients by providing evidence of what products may work best for certain conditions.
Patients can record their experiences in an app that will allow for data collection on purchases, use and patient-reported outcomes.
The app does not record patient identification data. The information will be uploaded to Ole Miss scientists for research on the products.
Angie Calhoun, Founder and CEO of the Mississippi Cannabis Patients Alliance, said “This agreement represents a significant step forward via a proprietary system that only patients in Mississippi can use. The University of Mississippi, Releaf App, and MCPA are offering a safe and effective platform for patients to report their results in a way that will assist future patients, while gaining valuable knowledge for themselves, and providing the industry and researchers with information about medical cannabis use, outcomes and so much more.”
JACKSON — The Mississippi Cannabis Patients Alliance is proud to announce a collaborative agreement with the University of Mississippi and the Releaf App.
For many decades, robust research-based data collection and analysis of medical cannabis outcomes have been lacking. This new research program will help the industry, regulators, practitioners, and, most importantly, patients by providing evidence of what products may work best for certain debilitating medical conditions and much more. With their participation, Mississippi patients, research sponsors, and dispensaries can help Mississippi make history by participating in medical cannabis research studies.
Through this partnership, participating patients can record their experiences in an easy-to-use app. The reporting system will allow data collection on purchases, use, and patient-reported outcomes, while protecting the privacy of the patient. These non-patient identifiable data will be uploaded to allow research on medical cannabis by scientists at the University of Mississippi. This research will allow health professionals, manufacturers, dispensaries, and patients to gain valuable knowledge on how well various medical cannabis products can provide relief in various conditions.
A new research program is underway that will take user feedback on cannabis treatment outcomes to better inform which strain of the plant or administration method is best for various medical needs. Angie Calhoun, CEO of the Mississippi Cannabis Patients Alliance, says patients can easily spend thousands of dollars trying to find which version of cannabis is best suited for them.
“When they go into that dispensary, there will be less trial in the future, and they’re actually helping other patients in the future, to be able to walk in and say ‘Okay, I have this condition, and I’m going to be able to treat it with this medicine,’” says Calhoun.
The research will be collected through the Releaf app, and data will be made available to researchers at the University of Mississippi as well as the dispensary that sold the product. Patients will be able to anonymously log what they purchased and how it affected things like sleep, mood and pain similar to a digital diary. Larry Walker is the Interim Director of the National Center for Cannabis Research and Education at the University of Mississippi. He says they have been conducting federal research on cannabis for more than 50 years, but this would be a major step toward researching patient outcomes.
“Understanding benefits that might be derived from it, what doses, what roots of administration, what conditions are they beneficial for,” says Walker. “And hopefully into full-scale clinical studies with the [University of Mississippi Medical Center], collaborating with them to study specific patient populations, specific doses and roots of administration.”
The Releaf app is already available on various app stores, and researchers say it will take time to gather this data as more dispensaries and forms of cannabis come online in Mississippi.
The Mississippi Cannabis Patients Alliance is proud to announce a collaborative agreement with the University of Mississippi and the Releaf App.
For many decades, robust research-based data collection and analysis of medical cannabis outcomes have been lacking. This new research program will help the industry, regulators, practitioners, and, most importantly, patients by providing evidence of what products may work best for certain debilitating medical conditions and much more. With their participation, Mississippi patients, research sponsors, and dispensaries can help Mississippi make history by participating in medical cannabis research studies.
Through this partnership, participating patients can record their experiences in an easy-to-use app. The reporting system will allow data collection on purchases, use, and patient-reported outcomes, while protecting the privacy of the patient. These non-patient identifiable data will be uploaded to allow research on medical cannabis by scientists at the University of Mississippi. This research will allow health professionals, manufacturers, dispensaries, and patients to gain valuable knowledge on how well various medical cannabis products can provide relief in various conditions.
“This agreement represents a significant step forward via a proprietary system that only patients in Mississippi can use,” Angie Calhoun, Founder and CEO of the Mississippi Cannabis Patients Alliance, said. “The University of Mississippi, Releaf App, and MCPA are offering a safe and effective platform for patients to report their results in a way that will assist future patients, while gaining valuable knowledge for themselves, and providing the industry and researchers with information about medical cannabis use, outcomes and so much more.”
“We at the University of Mississippi are excited about the potential of this program to understand details of medical cannabis product use and outcomes under our state program. We believe this will lay the groundwork for more robust research programs here and nationwide,” said Dr. Larry Walker, interim director of the National Center for Cannabis Research and Education (NCCRE) at the School of Pharmacy, University of Mississippi.
JACKSON, Miss. (WJTV) – A new partnership is working to bring innovative help and research to medical marijuana patients in Mississippi.
The University of Mississippi, the Mississippi Cannabis Patients Alliance (MCPA) and the ReLeaf App are working to streamline people’s medical cannabis usage according to their medical needs.
The ReLeaf App will connect symptoms and then provided catered scientific research to patients helping them determine specific dosage and medical cannabis strains to elevate their symptoms.
‘The state threw them to the wolves’: Health department struggles to manage massive medical marijuana program
MCPA Founder Angie Calhoun said this program is HIPPA compliant, so people can get the help they need without worrying about their information being leaked.
“When you’re in the app, and you’ll be able to say, well, ‘I used X, Y, Z brand for this debilitating medical condition,’ and then we’ll be able to gather the data which you’ll be able to tell us. ‘Well, yes, it did work for me. Well, ah, no it didn’t.’ And you can you know, there’s just a host of questions that we can ask from our patients in that data. And then once that data is collected, we’ll have it analyzed in over time, really within a 90-day period or so, we’ll have legitimate data that will help our patients now and, in the future,” said Calhoun.
Adding this type of innovate program will eliminate wasted money through trial and error when finding what work for them.
JACKSON, Miss. — With dispensaries opening across Mississippi, the state’s medical cannabis program is now in full swing. But there are still some bumps in the road.
Medical marijuana may not be a cure-all, but it could bring relief to thousands of Mississippians suffering from diseases that cause chronic pain.
“I really noticed since I’ve been medicating, just with this medical cannabis in Mississippi, I mean, my life quality has really, really improved,” said cannabis patient Joshua Gee
JACKSON, Miss. — Mississippi’s new medical marijuana program is ramping up. There is a list of diseases and ailments for patients looking for relief from chronic pain and to help them cope.
“No insurance will be paying for medical cannabis, period. It will be straight out of a patient’s pocket,” said Angie Calhoun, CEO and founder of the Mississippi Cannabis Patients Alliance. “Research shows that typically, in a new medical market, that we will be looking at approximately anywhere between $275 and $300 an ounce and that’s a lot of money.”
JACKSON, Miss. (WLBT) – It will still be months before patients have access to medical marijuana in Mississippi, but businesses are getting the groundwork laid now that the first set of regulations are in place.
A sold out conference full of folks who are wanting to be involved in the Magnolia State’s new medical marijuana industry. Some who previously left the state to seek it out.
“To see this gathering of people here who are going to make it happen, it’s very exciting,” said Jonathan Brown, director of Local Opt In and potential patient. “And personally, I can’t wait to cross the threshold into my first medical marijuana dispensary here in Mississippi and safely acquire the medicine that God has used to save my life. So I’m pretty excited about it.”
There was a significant milestone this week. The deadline for cities and counties to opt out was May 3.
JACKSON, Miss. — There are a lot of puzzle pieces that need to fit together for the medical marijuana industry to be fully up and running and most of those are now in place.
WLBT is told 900 Mississippians have already applied and been certified for their medical marijuana cards. But there is a message that some of them are getting that has them wondering if they’ve done something wrong.
“So the patient will actually get an approval notice from the Department of Health,” described Angie Calhoun, founder, and CEO of the Mississippi Cannabis Patients Alliance. “And then they will get a second email that says your card is deactivated.”
Angie Calhoun with the Mississippi Cannabis Patients Alliance says not to panic.
“As soon as the Department of Revenue opens those dispensary doors, the Department of Health, they stay in close contact with each other, they will activate your patient card,” added Calhoun.
Timeline wise….
“We’re hearing that the testing facilities should be ready and operable come the middle of December,” noted Calhoun. “And so that means that hopefully, the Mississippi Department of Revenue will open the dispensary doors come the first of the year.”
BILOXI, Miss. — The Mississippi Cannabis Patients Alliance, a 501 C3 nonprofit, held a seminar for one purpose: “It’s important for our patients to know and realize how their medicine is grown and how it will be dispensed,” said Angie Calhoun.
“Everybody really has questions, and we’re here to walk our patients and even the curious through any of those questions about medical cannabis.”
Angie Calhoun is the CEO and founder of the group. The group represents any cannabis patients of Mississippi. She gathered cannabis dispensaries from across the country as well as local dispensaries to help answer those questions. Companies like Star Buds say transparency and advocacy is key to this industry.
“Patient Advocacy is our main point today, kind of getting the information out there that the patient is really looking for,” said Doug Stout, with Star Buds. “Things like getting your card, things of that nature. You know, really trying to make sure that the public gets the correct information to the best of our ability.”
Disclaimer
Neither MCPA nor the administrators of this website are responsible for the accuracy of the information on this website. The practitioners listed on this website are provided by a third party and are not independently verified by MCPA, neither as to whether the practitioners listed are licensed in the State of Mississippi for their respective profession nor as to whether such practitioners are qualified or permitted to provide certifications to medical cannabis patients in the State of Mississippi. The information provided herein is merely educational and all users should perform their own due diligence prior to engaging with any particular practitioner.